Presentation is loading. Please wait.

Presentation is loading. Please wait.

P16Ink4a Suppression of Lung Adenocarcinoma by Bmi-1 in the Presence of p38 Activation  Mi-Ok Lee, MSc, Hyeon-Jae Lee, MD, Mi-Ae Kim, MD, Eun-Kyung Kim,

Published byShona Ramsey Modified over 5 years ago

Similar presentations

Presentation on theme: "P16Ink4a Suppression of Lung Adenocarcinoma by Bmi-1 in the Presence of p38 Activation  Mi-Ok Lee, MSc, Hyeon-Jae Lee, MD, Mi-Ae Kim, MD, Eun-Kyung Kim,"— Presentation transcript:

1 p16Ink4a Suppression of Lung Adenocarcinoma by Bmi-1 in the Presence of p38 Activation 
Mi-Ok Lee, MSc, Hyeon-Jae Lee, MD, Mi-Ae Kim, MD, Eun-Kyung Kim, MD, Ji-Hyun Lee, MD, Jin-Hyung Heo, MD, Seung-Hyuk Lee, BS, Sang-Ho Cho, MD, Albert J. Fornace, MD, Hye-Cheol Jeong, MD, PhD, Hyuk-Jin Cha, PhD  Journal of Thoracic Oncology  Volume 6, Issue 3, Pages (March 2011) DOI: /JTO.0b013e ace Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Relative mRNA levels of tumor suppressors in lung tumor tissue, when compared with normal lung tissue. mRNA levels of the indicated tumor suppressors were determined by semiquantitative real-time PCR analysis. Graphic representation of quantified data (fold change when compared with normal tissue) is also shown. p16Ink4a (A), Gadd45a (B), and p21 (C). mRNA, messenger RNA; PCR, polymerase chain reaction. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e ace) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Activation of p38 MAPK in lung adenocarcinomas. A, p38 MAPK activity was determined by immunoblot analysis using antiphospho-p38 (pp38, upper panel) and antiphospho-MK2 (pMK2, middle panel) antibodies in the 10 patient samples (N, normal; T, tumor). Equal protein loading was verified by analysis of ERK2 (bottom panel). Lung adenocarcinoma samples were all positive to anti-Mcm7 antibody (top panel). B, Intensities of the bands corresponding to pp38 (as an indication of p38 activation) and pMK2 (as an indication of p38 activity) were measured using NIH imager J software ( and are presented in graphical form (* indicates samples with commonly positive to pp38, pMK2 and pp38 IHC). C, Human lung tissues (normal and/or cancer) were subjected to IHC using an antipp38 antibody. The regions of lung adenocarcinoma indicated by the dotted line were clearly positive (left panel). Magnified normal lung alveolar tissues (middle panel) and lung adenocarcinoma tissues (right panel) are shown (×100 magnification). Normal lung alveolar tissues were negative for pp38 MAPK staining. MAPK, mitogen-activated protein kinase; ERK2, extracellular signal-regulated kinase 2; IHC, immunohistochemistry. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e ace) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Requirement for p38 MAPK in OIS. A, p38 phosphorylation (p-P38) was compared between wt MEFs and p38KI/+ MEFs under 30 mJ/cm2 of UVB. β actin for loading control. B, H-Ras-induced senescence in MEFs was determined by β-galactosidase staining. Blue arrows indicate β-galactosidase-positive cells. C, Higher magnification images (×40 magnification) are shown with DAPI counterstaining. Black arrows indicate β-galactosidase-positive cells. D, p38 activation on H-Ras stable expression was determined in wt MEFs and p38KI/+ MEFs by immunoblotting for phospho-p38. p38 immunoblotting for loading control. MEF, mouse embryonic fibroblasts; UVB, ultraviolet B; DAPI, 6-diamidino-2-phenylindole; wt, wild type; OIS, oncogenically induced senescence. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e ace) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Elevated Bmi-1 or/and p16Ink4a methylation in lung adenocarcinoma. A, Fold change in Bmi-1 mRNA levels in lung adenocarcinoma, when compared with normal tissues. B, Bmi-1 levels in normal and cancer tissues (left panel), normal tissue (middle panel), and cancer tissue (right panel) were analyzed by IHC. Normal lung alveolar and bronchial tissues were negative for Bmi-1 staining (middle panel). The glandular structure with brown-colored nuclear staining represents lung adenocarcinoma (right panel). C, p16Ink4a promoter methylation levels were determined by MSP analysis (U, unmethylated; M, methylated). *p16Ink4a promoter methylation. mRNA, messenger RNA; IHC, immunohistochemistry; MSP, methylation-specific polymerase chain reaction. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e ace) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

6 FIGURE 5 Suppression of p16Ink4a expression by Bmi-1 in vitro. A, Protein expression of p16Ink4a under the indicated conditions was determined by immunoblot analysis using an antip16 antibody (top panel). Wip1, Bmi-1, and H-Ras expression levels were also analyzed by immunoblotting using the appropriate antibodies. ERK2 was analyzed as a control for protein loading (bottom panel). B, p16Ink4a mRNA expression levels were measured by real-time PCR. Fold changes in the levels of p16Ink4a are presented in graphical form. Statistical analysis (Student's t test) was performed as described in the Materials and Methods section (*p < 0.05). ERK, extracellular signal-regulated kinase; mRNA, messenger RNA; PCR, polymerase chain reaction. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e ace) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

7 FIGURE 6 Proposed model of human lung adenocarcinoma development in the presence of p38 MAPK activity. p38 activation may be triggered by oncogenic stresses and transduce signals that activate p16Ink4a expression, resulting in suppression of tumor growth. Tumors may evade tumor suppression through the inhibition of p16Ink4a expression, mediated either by the induction of Bmi-1 or by promoter methylation. MAPK, mitogen-activated protein kinase. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e ace) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "P16Ink4a Suppression of Lung Adenocarcinoma by Bmi-1 in the Presence of p38 Activation  Mi-Ok Lee, MSc, Hyeon-Jae Lee, MD, Mi-Ae Kim, MD, Eun-Kyung Kim,"

Similar presentations

Volume 56, Issue 5, Pages (November 1999)

Volume 56, Issue 5, Pages (November 1999)
Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation 

Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation 
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,

IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA–IIA Squamous Cell Lung Cancer Irrespective.

Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA–IIA Squamous Cell Lung Cancer Irrespective.
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Volume 132, Issue 3, Pages (March 2007)

Volume 132, Issue 3, Pages (March 2007)
Stephen Lory, PhD, Jeffrey K. Ichikawa, PhD  CHEST 

Stephen Lory, PhD, Jeffrey K. Ichikawa, PhD  CHEST 
Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer.

Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer.
Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ  Keiji Tanese, Yuuri Hashimoto, Zuzana Berkova, Yuling Wang, Felipe.

Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ  Keiji Tanese, Yuuri Hashimoto, Zuzana Berkova, Yuling Wang, Felipe.
Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis  Ruo-Chia Tseng, PhD, Jia-Ming Chang,

Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis  Ruo-Chia Tseng, PhD, Jia-Ming Chang,
Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in.

Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in.
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.

Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Volume 85, Issue 2, Pages (January 2014)

Volume 85, Issue 2, Pages (January 2014)
Thymic stromal lymphopoietin downregulates filaggrin expression by signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated.

Thymic stromal lymphopoietin downregulates filaggrin expression by signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated.
Activation of mitogen-activated protein kinases during preparation of vein grafts and modulation by a synthetic inhibitor  Costas Bizekis, MD, Giuseppe.

Activation of mitogen-activated protein kinases during preparation of vein grafts and modulation by a synthetic inhibitor  Costas Bizekis, MD, Giuseppe.
MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values  Geun Dong Lee, MD, PhD, Seung Eun Lee, MD,

MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values  Geun Dong Lee, MD, PhD, Seung Eun Lee, MD,
MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations 

MET Tyrosine Kinase Inhibitor Crizotinib (PF ) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations 
Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: Role in non–small cell lung cancer tumor proliferation 

Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: Role in non–small cell lung cancer tumor proliferation 
Ming Hong Shen, Paulina Samsel, Louise L

Ming Hong Shen, Paulina Samsel, Louise L
Erdr1 Attenuates Dermatophagoides farina Body Extract-Induced Atopic Dermatitis in NC/Nga Mice  Kyung Eun Kim, Myung Jin Jung, Younkyung Houh, Tae Sung.

Erdr1 Attenuates Dermatophagoides farina Body Extract-Induced Atopic Dermatitis in NC/Nga Mice  Kyung Eun Kim, Myung Jin Jung, Younkyung Houh, Tae Sung.

Similar presentations

Ads by Google